Research Points to Translational Path Toward Precision Immunotherapies for EGFR-Mutant NSCLC

Targeted Therapy Plus Immune Checkpoint Inhibitors: Research Opportunities, But No Improvement in Activity to Date

… Targeted Therapy Plus Immune Checkpoint Inhibitors: Research Opportunities, But No Improvement in Activity to Date …

Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC

… weight gain represents a promising avenue for further research. The successful combination of a GLP-1-RA and a TKI … treatment strategy. A new prospective cohort study by our research group specifically addresses this issue in patients …